triamterene has been researched along with Substance-Related Disorders in 2 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
Substance-Related Disorders: Disorders related to substance use or abuse.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
HELLER, H | 1 |
Armbruster, H | 1 |
Vetter, W | 1 |
Reck, G | 1 |
Beckerhoff, R | 1 |
Siegenthaler, W | 1 |
2 other studies available for triamterene and Substance-Related Disorders
Article | Year |
---|---|
REVIEW OF THE YEAR'S WORK: PHARMACOLOGY AND TOXICOLOGY.
Topics: Drug Therapy; Kidney Diseases; Nitrofurantoin; Substance-Related Disorders; Toxicology; Triamterene; | 1964 |
Severe arterial hypertension caused by chronical abuse of a topical mineralocorticoid.
Topics: Adult; Aldosterone; Clonidine; Drug Combinations; Drug Therapy, Combination; Female; Fluprednisolone | 1975 |